• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌的肿瘤细胞减灭术:可行性及发病率

Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity.

作者信息

Heintz A P, Hacker N F, Berek J S, Rose T P, Munoz A K, Lagasse L D

出版信息

Obstet Gynecol. 1986 Jun;67(6):783-8. doi: 10.1097/00006250-198606000-00007.

DOI:10.1097/00006250-198606000-00007
PMID:3010203
Abstract

Between 1974 and 1984, 70 patients underwent primary cytoreductive surgery for ovarian carcinoma at the University of California at Los Angeles. During the period of January 1974 to December 1978, optimal cytoreduction was achieved in 56.4% of the patients. With increased experience, this figure improved to 87.1% in the period of January 1979 to December 1983. The most common morbidity associated with the procedure was fever and prolonged ileus. Bowel resection was required in 20% of the patients and was not associated with increased morbidity. More liberal use of the end-to-end anastomosis stapling device facilitated low colon reanastomosis without colostomy, which contributed to the improved patient acceptance.

摘要

1974年至1984年间,70例卵巢癌患者在加利福尼亚大学洛杉矶分校接受了初次肿瘤细胞减灭术。在1974年1月至1978年12月期间,56.4%的患者实现了最佳肿瘤细胞减灭。随着经验的增加,这一数字在1979年1月至1983年12月期间提高到了87.1%。与该手术相关的最常见并发症是发热和肠梗阻持续时间延长。20%的患者需要进行肠切除,且这与并发症增加无关。更广泛地使用端端吻合吻合器有助于低位结肠再吻合而无需结肠造口术,这提高了患者的接受度。

相似文献

1
Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity.卵巢癌的肿瘤细胞减灭术:可行性及发病率
Obstet Gynecol. 1986 Jun;67(6):783-8. doi: 10.1097/00006250-198606000-00007.
2
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.上皮性卵巢癌初次肿瘤细胞减灭术时的肠切除术。
J Am Coll Surg. 2001 Dec;193(6):626-32. doi: 10.1016/s1072-7515(01)01090-0.
3
Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer.晚期卵巢癌患者行肠道切除的最佳肿瘤细胞减灭术结果。
World J Surg Oncol. 2016 Feb 29;14:58. doi: 10.1186/s12957-016-0800-1.
4
Splenectomy for optimal cytoreduction in ovarian cancer.卵巢癌最佳细胞减灭术中的脾切除术
Gynecol Oncol. 1986 Jul;24(3):392-4. doi: 10.1016/0090-8258(86)90319-7.
5
Ovarian carcinoma; second-look laparotomy postchemotherapy. Preliminary report.卵巢癌;化疗后二次剖腹探查术。初步报告。
Cleve Clin Q. 1981 Winter;48(4):365-71. doi: 10.3949/ccjm.48.4.365.
6
Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma.卵巢癌初次肿瘤细胞减灭术中不做结肠造口的直肠乙状结肠切除术。
Int Surg. 1989 Jan-Mar;74(1):10-2.
7
[Pelvic posterior exenteration with immediate colo-rectal anastomosis: is it justified and feasible in advanced stage ovarian carcinoma?].[盆腔后位脏器切除术并即刻结直肠吻合术:在晚期卵巢癌中是否合理且可行?]
Ann Chir. 2006 Oct;131(8):431-6. doi: 10.1016/j.anchir.2006.03.017. Epub 2006 Apr 21.
8
Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.晚期上皮性卵巢癌初次肿瘤细胞减灭术患者行直肠乙状结肠切除术及一期吻合术的发病率。
Gynecol Oncol. 2005 Dec;99(3):608-14. doi: 10.1016/j.ygyno.2005.07.112. Epub 2005 Sep 8.
9
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.在日常实践中,FIGO 分期 IIIC 至 IV 期卵巢、输卵管和腹膜癌患者的最大减瘤术:一项回顾性法国多中心研究。
Int J Gynecol Cancer. 2012 Oct;22(8):1337-43. doi: 10.1097/IGC.0b013e31826a3559.
10
Comparison of morbidity and survival between primary and interval cytoreductive surgery in patients after modified posterior pelvic exenteration for advanced ovarian cancer.改良后的后盆腔切除术治疗晚期卵巢癌患者的初次和间隔减瘤术后发病率和生存情况比较。
Int J Gynecol Cancer. 2012 Oct;22(8):1349-54. doi: 10.1097/IGC.0b013e318265d358.

引用本文的文献

1
Patterns of Treatment and Outcomes in Epithelial Ovarian Cancer: A Retrospective North Indian Single-Institution Experience.上皮性卵巢癌的治疗模式和结局:印度北部单中心回顾性经验。
JCO Glob Oncol. 2022 Nov;8:e2200032. doi: 10.1200/GO.22.00032.
2
Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer.术前淋巴细胞与单核细胞比值是Ⅲ-Ⅳ期上皮性卵巢癌肿瘤细胞减灭术效果欠佳的预测指标。
J Cancer. 2016 Aug 11;7(13):1772-1779. doi: 10.7150/jca.15724. eCollection 2016.
3
Evolution of surgery in advanced epithelial ovarian cancer in a dedicated gynaecologic oncology unit-seven year audit from a tertiary care centre in a developing country.
一家发展中国家三级医疗中心妇科肿瘤专科病房晚期上皮性卵巢癌手术治疗的七年回顾
Ecancermedicalscience. 2014 Apr 17;8:422. doi: 10.3332/ecancer.2014.422. eCollection 2014.
4
Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.扩散加权磁共振成像评估卵巢癌患者腹腔内种植部位,预测减瘤手术效果不佳的可能性。
Eur Radiol. 2013 Sep;23(9):2636-42. doi: 10.1007/s00330-013-2837-7. Epub 2013 Apr 19.
5
Preoperative [F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer.术前 [F]FDG PET/CT 预测上皮性卵巢癌患者的复发。
J Gynecol Oncol. 2012 Jan;23(1):28-34. doi: 10.3802/jgo.2012.23.1.28. Epub 2012 Jan 9.
6
Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?术前能否预测晚期上皮性卵巢癌的初次最佳肿瘤细胞减灭术?
World J Surg Oncol. 2010 Feb 19;8:11. doi: 10.1186/1477-7819-8-11.
7
Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies.人上皮性卵巢癌中孕激素受体A和B亚型:免疫组织化学和逆转录-聚合酶链反应研究
Br J Cancer. 2000 Dec;83(11):1488-94. doi: 10.1054/bjoc.2000.1463.
8
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc.尿激酶(uPA)及其抑制剂PAI-1对晚期卵巢癌(国际妇产科联盟(FIGO)IIIc期)患者生存的预后意义。
Br J Cancer. 1999 Apr;79(11-12):1746-51. doi: 10.1038/sj.bjc.6690278.
9
[Surgical therapy of ovarian cancer].
Arch Gynecol Obstet. 1987;242(1-4):26-35. doi: 10.1007/BF01783014.
10
An audit of surgical treatment of ovarian cancer in a metropolitan health region. Association of Obstetricians and Gynaecologists of the North East Thames Region.大都市健康区域内卵巢癌外科治疗的审计。东北泰晤士地区妇产科医生协会。
J R Soc Med. 1991 Apr;84(4):206-9. doi: 10.1177/014107689108400408.